http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007501808-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2004-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2007-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007501808-A
titleOfInvention Pharmaceutical composition comprising a plant material of Trichilia sp. Alone or in combination with other plant extracts for reversal / coping and / or prevention of ventricular fibrillation
abstract The present invention relates to plant materials of the Trichilia species alone or in one or more of the following plants in the treatment, reversal, treatment and / or prevention of ventricular fibrillation: Paulinia cubana (Muclidae), Croton moritibensis ( For use in combination with Genicillaceae) and Genghiber Offykinare (Gingeraceae). Products specifically included in the present invention include Trichilia species of plant material alone or in combination with extracts from other plants. The present invention also relates to plant extracts derived from plant materials, such as Trichilia katigua e jus, and one or more fractions in the treatment, treatment, prevention and / or reversal of ventricular fibrillation. Mention the use of fractions.
priorityDate 2003-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02096443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001509486-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000044483-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03167126-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02096441-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02096442-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452950141

Total number of triples: 30.